PPPaul N. Pfeiffer

Paul N. Pfeiffer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Paul N. Pfeiffer has a total of 88 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • On that day: Warnings of acute risk in narratives (WARN) of suicide attempts in adults

    by Kenneth R. Conner, Jaclyn C. Kearns, Anthony R. Pisani, Paul N. Pfeiffer, Valeria A. Cuellar Leal, Lauren M. Denneson, Courtney L. Bagge

  • Open Access

    Deprexis for Veteran Depression: Feasibility, Acceptability, and Preliminary Efficacy in an Open-Label Pilot Trial (Preprint)

    by Rahel Pearson, Emma Harris, Allison Metts, Christopher Graham Beevers, Paul N. Pfeiffer, Suzannah Creech

    Background: Depression carries the highest burden of mental health–related disability in the United States. Approximately 13% of military veterans report elevated rates of depression. Despite the availability of evidence-based treatments for depression, nearly 50% of veterans in need of mental health care remain untreated. Internet-based interventions show promise in reducing this gap; however, there are currently no standard self-guided internet-based interventions for depressive symptoms in veterans. Deprexis is one such intervention that leverages cognitive behavioral therapy to target depressive symptoms. Objective: This pilot study evaluated the feasibility, acceptability, and preliminary effectiveness of Deprexis, a fully self-guided internet-based intervention for depression, in US military veterans with mild to severe depressive symptoms. Methods: This open-label pilot trial recruited 19 veterans with mild to severe depression (mean age 55.5, SD 8.2 y; baseline Quick Inventory of Depressive Symptomatology—Self-Report [QIDS-SR]: mean 16.2, SD 4.1) for an 8-week course of Deprexis, with self-report assessments at baseline, posttreatment (8 wk), and follow-up (16 wk). Primary outcomes included depressive symptoms (QIDS-SR), functional disability (World Health Organization Disability Assessment Schedule 2.0), and symptom-related disability (Sheehan Disability Scale). Feasibility was assessed through recruitment and retention rates, and acceptability was measured using validated questionnaires (Credibility and Expectancy Questionnaire and Client Satisfaction Questionnaire). Multilevel models examined change over time, with effect sizes calculated using pooled SDs from unconditional models. Results: Recruitment and retention targets were met, with 15 out of 19 (79%) participants meeting the adherence criteria (ie, ≥60 min of active program use). Of these, 14 participants completed posttreatment questionnaires and were included in the completer analyses. The program received a positive acceptability rating: of the 18 participants who completed follow-up assessments, 78% (n=14) rated services as good or excellent and 72% (n=13) were satisfied with the amount of help received. No safety concerns were reported. Among completers (n=14), QIDS-SR scores decreased from baseline to posttreatment (estimate −2.22, SE 1.44; P =.14; d =−0.54, 95% CI −1.07 to 0.13) and follow-up (estimate −2.85, SE 1.19; P =.02; d =−0.70, 95% CI −1.21 to −0.08) with moderate-to-large effect sizes. Effect sizes were similar in the total sample. Functioning (World Health Organization Disability Assessment Schedule 2.0) improved among completers at follow-up (estimate −8.09, SE 3.80; P =.045; d =−0.41, 95% CI −0.96 to −0.05). Disability (Sheehan Disability Scale) did not significantly improve from baseline to posttreatment or follow-up. Conclusions: This pilot trial demonstrates that Deprexis is feasible and acceptable for veterans with mild to severe depression, with preliminary evidence of effectiveness for depressive symptoms. The delayed emergence of functional improvements and sustained gains at follow-up support the potential of this scalable intervention. The results provide a strong foundation for the ongoing randomized controlled trial.

  • Open Access

    Peer Support Intervention for Suicide Prevention Among High-Risk Adults in Michigan

    by Paul N. Pfeiffer, Kristen M. Abraham, Adrienne Lapidos, Eduardo Vega, Jennifer Jagusch, James Garlick, Sara Pasiak, Dara Ganoczy, H. Myra Kim, Brian Ahmedani, et al.

    Importance: Innovative approaches to address interpersonal risk factors for suicide attempts and suicidal ideation may help reduce persistently elevated suicide rates in the US.Objective: To determine whether Peers for Valued Living (PREVAIL), a posthospital peer support intervention, reduces suicide attempts and suicidal ideation among adults psychiatrically hospitalized for suicide risk.Design, Setting, and Participants: This single-masked, randomized clinical trial recruited adult psychiatric inpatients aged 18 years or older from 3 Michigan-based facilities between June 22, 2018, and December 30, 2022. The study compared 3 months of the PREVAIL intervention plus enhanced usual care with enhanced usual care only, with 3 months of postintervention follow-up.Intervention: One-on-one support from a peer specialist initiated during hospital admission and continued 3 months after discharge.Main Outcomes and Measures: Suicide attempts were measured using the Columbia Suicide Severity Rating Scale, and suicidal ideation was measured using the Beck Scale for Suicidal Ideation at 3 and 6 months after randomization.Results: Of 5310 patients screened, 455 were randomized using a minimization algorithm. A total of 229 participants were randomized to the PREVAIL peer mentorship arm (mean [SD] age, 32.4 [14.0] years, 134 women [58.5%]), and 226 were randomized to the enhanced usual care arm (mean [SD] age, 31.6 [13.5] years; 139 women [61.5%]). In the intention-to-treat sample with nonmissing data, the percentage of participants with any suicide attempt over 6 months (including participants who only completed 3-month follow-up assessments) was 17.2% (28 of 163) for enhanced usual care and 14.9% (24 of 161 with 2 deaths by suicide) for PREVAIL. Mean (SD) suicidal ideation scores were 4.3 (95% CI, 3.2-5.3) for enhanced usual care and 4.9 (95% CI, 3.7-6.1) for PREVAIL at 6 months. There were no statistically significant effects of the intervention for either outcome in the primary analyses. In post hoc analyses, the interaction between study arm and the COVID-19 pandemic was statistically significant. The enhanced usual care arm had a mean (SD) 6-month suicidal ideation score of 3.5 (6.1) before and 6.1 (7.4) after the pandemic vs the PREVAIL arm (mean [SD] scores, 5.0 [7.7] and 4.5 [6.6], respectively). There were 2 study-related adverse events, with 1 resulting in participant withdrawal from the intervention arm.Conclusions and Relevance: In this randomized clinical trial, the peer-delivered PREVAIL intervention up to 3 months after discharge did not significantly differ from enhanced usual care in terms of reducing subsequent suicide attempts or suicidal ideation.Trial Registration: ClinicalTrials.gov Identifier: NCT03373916


  • Open Access

    Development, Implementation, and Evaluation Methods for Dashboards in Health Care: Scoping Review

    by Danielle Helminski, Jeremy B Sussman, Paul N Pfeiffer, Alex N Kokaly, Allison Ranusch, Anjana Deep Renji, Laura J Damschroder, Zach Landis-Lewis, Jacob E Kurlander

    Background: Dashboards have become ubiquitous in health care settings, but to achieve their goals, they must be developed, implemented, and evaluated using methods that help ensure they meet the needs of end users and are suited to the barriers and facilitators of the local context. Objective: This scoping review aimed to explore published literature on health care dashboards to characterize the methods used to identify factors affecting uptake, strategies used to increase dashboard uptake, and evaluation methods, as well as dashboard characteristics and context. Methods: MEDLINE, Embase, Web of Science, and the Cochrane Library were searched from inception through July 2020. Studies were included if they described the development or evaluation of a health care dashboard with publication from 2018‐2020. Clinical setting, purpose (categorized as clinical, administrative, or both), end user, design characteristics, methods used to identify factors affecting uptake, strategies to increase uptake, and evaluation methods were extracted. Results: From 116 publications, we extracted data for 118 dashboards. Inpatient (45/118, 38.1%) and outpatient (42/118, 35.6%) settings were most common. Most dashboards had ≥2 stated purposes (84/118, 71.2%); of these, 54 of 118 (45.8%) were administrative, 43 of 118 (36.4%) were clinical, and 20 of 118 (16.9%) had both purposes. Most dashboards included frontline clinical staff as end users (97/118, 82.2%). To identify factors affecting dashboard uptake, half involved end users in the design process (59/118, 50%); fewer described formative usability testing (26/118, 22%) or use of any theory or framework to guide development, implementation, or evaluation (24/118, 20.3%). The most common strategies used to increase uptake included education (60/118, 50.8%); audit and feedback (59/118, 50%); and advisory boards (54/118, 45.8%). Evaluations of dashboards (84/118, 71.2%) were mostly quantitative (60/118, 50.8%), with fewer using only qualitative methods (6/118, 5.1%) or a combination of quantitative and qualitative methods (18/118, 15.2%). Conclusions: Most dashboards forego steps during development to ensure they suit the needs of end users and the clinical context; qualitative evaluation—which can provide insight into ways to improve dashboard effectiveness—is uncommon. Education and audit and feedback are frequently used to increase uptake. These findings illustrate the need for promulgation of best practices in dashboard development and will be useful to dashboard planners.


  • Open Access

    The Evaluation of a Web-Based Intervention (Deprexis) to Decrease Depression and Restore Functioning in Veterans: Protocol for a Randomized Controlled Trial

    by Rahel Pearson, Christopher G Beevers, Joseph Mignogna, Justin Benzer, Paul N Pfeiffer, Edward Post, Suzannah K Creech

    Background: Depressive symptoms are common in veterans, and the presence of these symptoms increases disability as well as suicidal thoughts and behaviors. However, there is evidence that these symptoms often go untreated. Intervening before symptoms become severe and entrenched is related to better long-term outcomes, including improved functioning and less disease chronicity. Computer-delivered interventions may be especially appropriate for those veterans with mild to moderate depressive symptoms, because these interventions can require fewer resources and have lower barriers to access and thus have potential for wider reach. Despite this potential, there is a dearth of research examining computerized interventions for depressive symptoms in veteran samples. Objective: The aim of this study is to evaluate the efficacy of Deprexis (GAIA AG), a computerized intervention for depressive symptoms and related functional impairment. Methods: Veterans will be recruited through the US Department of Veterans Affairs electronic medical record and through primary care and specialty clinics. First, qualitative interviews will be completed with a small subset of veterans (n=16-20) to assess the acceptability of treatment procedures. Next, veterans (n=132) with mild to moderate depressive symptoms will be randomly assigned to the fully automated Deprexis intervention or a treatment-as-usual control group. The primary outcomes will be self-reported depressive symptoms and various dimensions of psychosocial functioning. Results: This project was funded in May 2024, and data collection will be conducted between October 2024 and April 2029. Overall, 4 participants have been recruited as of the submission of the manuscript, and data analysis is expected in June 2029, with initial results expected in November 2029. Conclusions: This study will provide initial evidence for the efficacy of self-guided, computerized interventions for depressive symptoms and functional impairment in veterans. If effective, these types of interventions could improve veteran access to low-resource psychosocial treatments. Trial Registration: ClinicalTrials.gov NCT06217198; https://www.clinicaltrials.gov/study/NCT06217198 International Registered Report Identifier (IRRID): PRR1-10.2196/59119


  • Open Access

    Scoping review of dashboards in health care: why, how, and for whom they have been developed, implemented, and evaluated (Preprint)

    by Danielle Helminski, Jeremy B Sussman, Paul N Pfeiffer, Alex N Kokaly, Allison Ranusch, Anjana Deep Renji, Laura J Damschroder, Zach Landis-Lewis, Jacob E Kurlander

    BACKGROUND While dashboards are frequently used by health systems to monitor and improve performance, little is known about their characteristics and the processes used to incorporate them into practice. OBJECTIVE This scoping review aimed to explore published literature on health care dashboards to summarize why, how, and for whom they have been developed, implemented, and evaluated. METHODS MEDLINE, EMBASE, Web of Science and the Cochrane Library were searched from inception through July 2020. Studies were included if they described the development or evaluation of a health care dashboard with publication since 2015. Clinical setting, purpose (categorized as clinical, administrative, or both), and end-user were extracted for all studies. Data on dashboard development, design characteristics, implementation strategies, and evaluation were extracted only for studies published from 2018-2020. RESULTS Data was extracted for 199 dashboards described in 193 publications. The most common settings in which dashboards were used were inpatient (n=81/199, 40.7%) and outpatient clinics (n=68/199, 34.2%). Most dashboards had ≥2 stated purposes (n=142/199, 71.4%); of these, 97/199 (48.7%) were administrative, 68/199 (34.2%) were clinical, and 31/199 (15.6%) met both criteria. Most dashboards included front-line clinical staff as end-users (n=154/199, 77.4%). In the 118 dashboards published from 2018-2020, half involved end-users in the design process (n=59/118, 50.0%); fewer described formative usability testing (n=26/118, 22.0%) or use of any theory or framework to guide development, implementation, or evaluation (n=24/118, 20.3%). Dashboards tended to be web-based (n=41/118, 34.7%) or embedded directly into the electronic health record (n=17/118, 14.4%). Common implementation strategies used alongside dashboards included education (n=60/118, 50.8%), audit and feedback (n=59/118, 50.0%), and advisory boards (n=54/118, 45.8%). Evaluations of dashboards (n=84/118, 71.2%) were mostly quantitative (n=60/118, 50.8%), or mixed methods, combining dashboard or health record data with qualitative findings (n=18/118, 15.2%). CONCLUSIONS Dashboards in health care have been used in diverse settings, for multiple purposes and varied end users. The complexity of many dashboards – serving many purposes and end users at once – and the frequent expectation that clinicians will use them underscores the importance of systematic design and evaluation to ensure they are having the intended outcomes. Future work is needed to identify best practices for the development, implementation, and evaluation of health care dashboards. INTERNATIONAL REGISTERED REPORT RR2-10.2196/34894

  • Open Access

    The Evaluation of a Web-Based Intervention (Deprexis) to Decrease Depression and Restore Functioning in Veterans: Protocol for a Randomized Controlled Trial (Preprint)

    by Rahel Pearson, Christopher G Beevers, Joseph Mignogna, Justin Benzer, Paul N Pfeiffer, Edward Post, Suzannah K Creech

    BACKGROUND Depressive symptoms are common in veterans, and the presence of these symptoms increases disability as well as suicidal thoughts and behaviors. However, there is evidence that these symptoms often go untreated. Intervening before symptoms become severe and entrenched is related to better long-term outcomes, including improved functioning and less disease chronicity. Computer-delivered interventions may be especially appropriate for those veterans with mild to moderate depressive symptoms, because these interventions can require fewer resources and have lower barriers to access and thus have potential for wider reach. Despite this potential, there is a dearth of research examining computerized interventions for depressive symptoms in veteran samples. OBJECTIVE The aim of this study is to evaluate the efficacy of Deprexis (GAIA AG), a computerized intervention for depressive symptoms and related functional impairment. METHODS Veterans will be recruited through the US Department of Veterans Affairs electronic medical record and through primary care and specialty clinics. First, qualitative interviews will be completed with a small subset of veterans (n=16-20) to assess the acceptability of treatment procedures. Next, veterans (n=132) with mild to moderate depressive symptoms will be randomly assigned to the fully automated Deprexis intervention or a treatment-as-usual control group. The primary outcomes will be self-reported depressive symptoms and various dimensions of psychosocial functioning. RESULTS This project was funded in May 2024, and data collection will be conducted between October 2024 and April 2029. Overall, 4 participants have been recruited as of the submission of the manuscript, and data analysis is expected in June 2029, with initial results expected in November 2029. CONCLUSIONS This study will provide initial evidence for the efficacy of self-guided, computerized interventions for depressive symptoms and functional impairment in veterans. If effective, these types of interventions could improve veteran access to low-resource psychosocial treatments. CLINICALTRIAL ClinicalTrials.gov NCT06217198; https://www.clinicaltrials.gov/study/NCT06217198 INTERNATIONAL REGISTERED REPORT PRR1-10.2196/59119

  • Open Access

    Dashboards in Health Care Settings: Protocol for a Scoping Review

    by Danielle Helminski, Jacob E Kurlander, Anjana Deep Renji, Jeremy B Sussman, Paul N Pfeiffer, Marisa L Conte, Oliver J Gadabu, Alex N Kokaly, Rebecca Goldberg, Allison Ranusch, et al.

    Background: Health care organizations increasingly depend on business intelligence tools, including “dashboards,” to capture, analyze, and present data on performance metrics. Ideally, dashboards allow users to quickly visualize actionable data to inform and optimize clinical and organizational performance. In reality, dashboards are typically embedded in complex health care organizations with massive data streams and end users with distinct needs. Thus, designing effective dashboards is a challenging task and theoretical underpinnings of health care dashboards are poorly characterized; even the concept of the dashboard remains ill-defined. Researchers, informaticists, clinical managers, and health care administrators will benefit from a clearer understanding of how dashboards have been developed, implemented, and evaluated, and how the design, end user, and context influence their uptake and effectiveness. Objective: This scoping review first aims to survey the vast published literature of “dashboards” to describe where, why, and for whom they are used in health care settings, as well as how they are developed, implemented, and evaluated. Further, we will examine how dashboard design and content is informed by intended purpose and end users. Methods: In July 2020, we searched MEDLINE, Embase, Web of Science, and the Cochrane Library for peer-reviewed literature using a targeted strategy developed with a research librarian and retrieved 5188 results. Following deduplication, 3306 studies were screened in duplicate for title and Any abstracts mentioning a health care dashboard were retrieved in full text and are undergoing duplicate review for eligibility. Articles will be included for data extraction and analysis if they describe the development, implementation, or evaluation of a dashboard that was successfully used in routine workflow. Articles will be excluded if they were published before 2015, the full text is unavailable, they are in a non-English language, or they describe dashboards used for public health tracking, in settings where direct patient care is not provided, or in undergraduate medical education. Any discrepancies in eligibility determination will be adjudicated by a third reviewer. We chose to focus on articles published after 2015 and those that describe dashboards that were successfully used in routine practice to identify the most recent and relevant literature to support future dashboard development in the rapidly evolving field of health care informatics. Results: All articles have undergone dual review for title and abstract, with a total of 2019 articles mentioning use of a health care dashboard retrieved in full text for further review. We are currently reviewing all full-text articles in duplicate. We aim to publish findings by mid-2022. Findings will be reported following guidance from the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) checklist. Conclusions: This scoping review will provide stakeholders with an overview of existing dashboard tools, highlighting the ways in which dashboards have been developed, implemented, and evaluated in different settings and for different end user groups, and identify potential research gaps. Findings will guide efforts to design and use dashboards in the health care sector more effectively. International Registered Report Identifier (IRRID): DERR1-10.2196/34894


  • Characterising suicide-related self-disclosure by peer specialists: a qualitative analysis of audio-recorded sessions

    by Casimir Klim, C. Ann Vitous, Deborah Keller-Cohen, Eduardo Vega, Jane Forman, Adrienne Lapidos, Kristen M. Abraham, Paul N. Pfeiffer

    : We characterised peer support specialists’ self-disclosures related to suicide and recipient responses to inform services for high-risk individuals that may include peer support.: We used an indu...